Back to Search
Start Over
Why cure, why now?
- Source :
- Journal of Medical Ethics; Feb2017, Vol. 43 Issue 2, p67-70, 4p
- Publication Year :
- 2017
-
Abstract
- Combination antiretroviral therapy (cART) is highly effective at preventing morbidity and mortality due to infection with human immunodeficiency virus (HIV), but does not eradicate the virus. Consequently, cART must be administered life-long. Recent progress has stimulated research towards a cure of HIV infection. Approaches under investigation include hematopoietic stem cell transplantation, latency reactivating agents, immune based therapies, and cell-based therapies. Each of these approaches carries potential risks that must be weighed against the availability of safe and effective cART. Balancing the risks and benefits of this research poses unique challenges to potential study participants, clinicians and investigators. [ABSTRACT FROM AUTHOR]
- Subjects :
- THERAPEUTICS
HIV infections
HIV-positive persons
MEDICAL care
PUBLIC health
AIDS treatment
HEALTH
HIV prevention
MEDICAL research ethics
ANTI-HIV agents
PATIENT selection
DRUG design
AIDS vaccines
HEMATOPOIETIC stem cell transplantation
MEDICAL research
RESEARCH funding
VIRAL physiology
DISEASE eradication
ETHICS
Subjects
Details
- Language :
- English
- ISSN :
- 03066800
- Volume :
- 43
- Issue :
- 2
- Database :
- Complementary Index
- Journal :
- Journal of Medical Ethics
- Publication Type :
- Academic Journal
- Accession number :
- 120970765
- Full Text :
- https://doi.org/10.1136/medethics-2015-103113